The goal of this clinical trial is to evaluate both the technical success and efficacy of using the LOBOâ„¢ device in patients undergoing embolization of Pulmonary Arteriovenous Malformations (PAVM). The main question\[s\] it aims to answer \[is/are\]: * What is the technical success rate, the number of LOBOâ„¢ devices needed for occlusion, and time to occlusion for each feeding artery during PAVM embolization using the LOBOâ„¢ device? * What is the short-term occlusion rate of the LOBOâ„¢ device for PAVM embolization (6 months post-embolization)? * What are the medium- and long-term occlusion rate of the LOBOâ„¢ device in PAVMs (12 months and 36 months post embolization)? Researchers will compare the percentage of LOBOâ„¢ embolized PAVMs that develop recanalization at 6, 12, and 36- month intervals compared to percentage of conventionally embolized PAVMs that develop recanalization at the same intervals. Participants will undergo the embolization procedure and be followed for 36 months after the procedure. There will be a total of 4 study visits: * Treatment visit * 6-Month Follow-up visit * 12-Month Follow-up visit * 36-Month Follow-up visit At each clinical follow-up visit participants will undergo imaging with a computed tomography angiography (CTA) of the chest.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Proportion of Technical Success
Timeframe: At treatment until stasis is achieved. Approximately 1 - 2 hours.